Opinion | Keep Our Foot on the Gas for Clinical Trial Diversity
The COVID-19 pandemic sparked rapid innovation and adoption of new methodologies and practices across clinical trials. It also allowed the world to see the difficulty of ensuring diversity and access to those trials — a challenge we’ve faced for many years. Innovators in biopharma, life-science technology companies, and clinical research organizations (CROs) partnered with the […]